MBX Biosciences, Inc Common Stock (MBX) had the lowest return in January 2025 by a mid-cap US stock, returning -46.8%.
| ASSET | MONTH | % RETURN |
|---|---|---|
MBX Biosciences, Inc Common Stock (MBX) | January 2025 | -46.76% |
Dyne Therapeutics (DYN) | January 2025 | -40.43% |
BitVentures (BVC) | January 2025 | -40.35% |
QMMM Holdings Limited Ordinary Shares (QMMM) | January 2025 | -39.69% |
Quantum Computing (QUBT) | January 2025 | -37.81% |
Kodiak Sciences (KOD) | January 2025 | -35.61% |
Aehr Test Systems (AEHR) | January 2025 | -32.8% |
Agilysys (AGYS) | January 2025 | -32.07% |
Oruka Therapeutics (ORKA) | January 2025 | -32% |
Establishment Labs (ESTA) | January 2025 | -31.6% |
SoundHound AI (SOUN) | January 2025 | -30.89% |
D-Wave Quantum (QBTS) | January 2025 | -30.12% |
T1 Energy (TE) | January 2025 | -30.11% |
Ondas (ONDS) | January 2025 | -30% |
Erasca (ERAS) | January 2025 | -27.03% |
CNX Resources (CNX) | January 2025 | -26.61% |
Signet Jewelers (SIG) | January 2025 | -26.54% |
Maase (MAAS) | January 2025 | -25.46% |
Regencell Bioscience (RGC) | January 2025 | -25.21% |
Mercury General (MCY) | January 2025 | -25.03% |
POET Technologies (POET) | January 2025 | -23.56% |
Manhattan Associates (MANH) | January 2025 | -23.28% |
Xometry (XMTR) | January 2025 | -23.23% |
Crinetics Pharmaceuticals (CRNX) | January 2025 | -22.35% |
AMC Entertainment (AMC) | January 2025 | -22.25% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.